glp-1 drugs in development Market Overview: Agonists and the Obesity Market | Blog Trends in the Development of

however, clinical trials assessing the efficacy of oral semaglutide (Rybelsus) in obesity are still enrolling participants (NCT05442450)

This article explores how GLP-1 works, how your genes influence GLP-1 levels, and how your genes interact with your response to GLP-1 RA medications for weight loss or diabetes

Clin Pharmacol Therapeut

Thyroid Health: We prioritize safety by screening for personal or family history of medullary thyroid carcinoma (MTC) and Multiple Endocrine Neoplasia syndrome type 2 before recommending semaglutide, given its associated risks

Ciarmiello A, Giovannini E, Riondato M, et al

Int J Obes 38(5):689697 Aroda VR et al (2023) Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes